The global single-use equipment for biopharmaceutical market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for biopharmaceuticals and the need for single-use equipment in order to reduce contamination risks. The North American region is expected to dominate the global single-use equipment for biopharmaceutical market during the forecast period, due to its high adoption rate of new technologies and stringent regulatory requirements.
Some Of The Growth Factors Of This Market:
- Biopharmaceuticals are used in the treatment of various diseases such as cancer, diabetes, arthritis and Alzheimer's disease among others which are on the rise globally due to changing lifestyles and aging population demographics.
- Increasing R&D investments by pharmaceutical companies coupled with technological advancements in drug discovery process will drive growth in this market over the forecast period (2017-2022) 5) Increasing government funding for research & development activities will also fuel growth in this market over the forecast period (2017-2022).
Industry Growth Insights published a new data on “Single-Use Equipment for Biopharmaceutical Market”. The research report is titled “Single-Use Equipment for Biopharmaceutical Market research by Types (Single-use Bioreactors (SUBs), Membrane Adsorbers, Mixing, Tangential Flow Filtration, Tubing, Connectors, Preassembled Tubing and Rigging, Depth Filtration, Buffer Containers), By Applications (Hospital, Clinic), By Players/Companies Merck KGaA, Danaher (Pall), Saint-Gobain Biopharm, Nordson, GE Healthcare, Progenics Pharmaceuticals, Patheon, 3M, Eppendorf, Advanced Scientifics, Gore, Thermo Fisher Scientific”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Single-Use Equipment for Biopharmaceutical Market Research Report
By Type
Single-use Bioreactors (SUBs), Membrane Adsorbers, Mixing, Tangential Flow Filtration, Tubing, Connectors, Preassembled Tubing and Rigging, Depth Filtration, Buffer Containers
By Application
Hospital, Clinic
By Companies
Merck KGaA, Danaher (Pall), Saint-Gobain Biopharm, Nordson, GE Healthcare, Progenics Pharmaceuticals, Patheon, 3M, Eppendorf, Advanced Scientifics, Gore, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Single-Use Equipment for Biopharmaceutical Market Report Segments:
The global Single-Use Equipment for Biopharmaceutical market is segmented on the basis of:
Types
Single-use Bioreactors (SUBs), Membrane Adsorbers, Mixing, Tangential Flow Filtration, Tubing, Connectors, Preassembled Tubing and Rigging, Depth Filtration, Buffer Containers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck KGaA
- Danaher (Pall)
- Saint-Gobain Biopharm
- Nordson
- GE Healthcare
- Progenics Pharmaceuticals
- Patheon
- 3M
- Eppendorf
- Advanced Scientifics
- Gore
- Thermo Fisher Scientific
Highlights of The Single-Use Equipment for Biopharmaceutical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single-use Bioreactors (SUBs)
- Membrane Adsorbers
- Mixing
- Tangential Flow Filtration
- Tubing
- Connectors
- Preassembled Tubing and Rigging
- Depth Filtration
- Buffer Containers
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Single-Use Equipment for Biopharmaceutical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Single-use equipment is any piece of equipment that is used only once and then disposed of. This includes devices such as syringes, vials, and pumps.
Some of the major companies in the single-use equipment for biopharmaceutical market are Merck KGaA, Danaher (Pall), Saint-Gobain Biopharm, Nordson, GE Healthcare, Progenics Pharmaceuticals, Patheon, 3M, Eppendorf, Advanced Scientifics, Gore, Thermo Fisher Scientific.
The single-use equipment for biopharmaceutical market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Single-Use Equipment for Biopharmaceutical Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Single-Use Equipment for Biopharmaceutical Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Single-Use Equipment for Biopharmaceutical Market - Supply Chain
4.5. Global Single-Use Equipment for Biopharmaceutical Market Forecast
4.5.1. Single-Use Equipment for Biopharmaceutical Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Single-Use Equipment for Biopharmaceutical Market Size (000 Units) and Y-o-Y Growth
4.5.3. Single-Use Equipment for Biopharmaceutical Market Absolute $ Opportunity
5. Global Single-Use Equipment for Biopharmaceutical Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Type
5.3.1. Single-use Bioreactors (SUBs)
5.3.2. Membrane Adsorbers
5.3.3. Mixing
5.3.4. Tangential Flow Filtration
5.3.5. Tubing
5.3.6. Connectors
5.3.7. Preassembled Tubing and Rigging
5.3.8. Depth Filtration
5.3.9. Buffer Containers
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Single-Use Equipment for Biopharmaceutical Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Single-Use Equipment for Biopharmaceutical Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Single-Use Equipment for Biopharmaceutical Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Single-Use Equipment for Biopharmaceutical Demand Share Forecast, 2019-2026
9. North America Single-Use Equipment for Biopharmaceutical Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Type
9.7.1. Single-use Bioreactors (SUBs)
9.7.2. Membrane Adsorbers
9.7.3. Mixing
9.7.4. Tangential Flow Filtration
9.7.5. Tubing
9.7.6. Connectors
9.7.7. Preassembled Tubing and Rigging
9.7.8. Depth Filtration
9.7.9. Buffer Containers
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Single-Use Equipment for Biopharmaceutical Demand Share Forecast, 2019-2026
10. Latin America Single-Use Equipment for Biopharmaceutical Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Type
10.7.1. Single-use Bioreactors (SUBs)
10.7.2. Membrane Adsorbers
10.7.3. Mixing
10.7.4. Tangential Flow Filtration
10.7.5. Tubing
10.7.6. Connectors
10.7.7. Preassembled Tubing and Rigging
10.7.8. Depth Filtration
10.7.9. Buffer Containers
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Single-Use Equipment for Biopharmaceutical Demand Share Forecast, 2019-2026
11. Europe Single-Use Equipment for Biopharmaceutical Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Type
11.7.1. Single-use Bioreactors (SUBs)
11.7.2. Membrane Adsorbers
11.7.3. Mixing
11.7.4. Tangential Flow Filtration
11.7.5. Tubing
11.7.6. Connectors
11.7.7. Preassembled Tubing and Rigging
11.7.8. Depth Filtration
11.7.9. Buffer Containers
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Single-Use Equipment for Biopharmaceutical Demand Share, 2019-2026
12. Asia Pacific Single-Use Equipment for Biopharmaceutical Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Type
12.7.1. Single-use Bioreactors (SUBs)
12.7.2. Membrane Adsorbers
12.7.3. Mixing
12.7.4. Tangential Flow Filtration
12.7.5. Tubing
12.7.6. Connectors
12.7.7. Preassembled Tubing and Rigging
12.7.8. Depth Filtration
12.7.9. Buffer Containers
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Single-Use Equipment for Biopharmaceutical Demand Share, 2019-2026
13. Middle East & Africa Single-Use Equipment for Biopharmaceutical Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Single-Use Equipment for Biopharmaceutical Market Size and Volume Forecast by Type
13.7.1. Single-use Bioreactors (SUBs)
13.7.2. Membrane Adsorbers
13.7.3. Mixing
13.7.4. Tangential Flow Filtration
13.7.5. Tubing
13.7.6. Connectors
13.7.7. Preassembled Tubing and Rigging
13.7.8. Depth Filtration
13.7.9. Buffer Containers
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Single-Use Equipment for Biopharmaceutical Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Single-Use Equipment for Biopharmaceutical Market: Market Share Analysis
14.2. Single-Use Equipment for Biopharmaceutical Distributors and Customers
14.3. Single-Use Equipment for Biopharmaceutical Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Merck KGaA
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Danaher (Pall)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Saint-Gobain Biopharm
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Nordson
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. GE Healthcare
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Progenics Pharmaceuticals
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Patheon
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. 3M
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Eppendorf
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Advanced Scientifics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Gore
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Thermo Fisher Scientific
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
&
